Clinical practice guidelines for laboratory diagnosis of epidermolysis bullosa
- PMID: 31090061
- PMCID: PMC7064925
- DOI: 10.1111/bjd.18128
Clinical practice guidelines for laboratory diagnosis of epidermolysis bullosa
Abstract
Linked Comment:
Figures


Comment in
-
Epidermolysis bullosa: diagnostic guidelines in the laboratory setting.Br J Dermatol. 2020 Mar;182(3):526-527. doi: 10.1111/bjd.18377. Epub 2019 Aug 22. Br J Dermatol. 2020. PMID: 31436321 No abstract available.
References
-
- Zeng X, Zhang Y, Kwong JSW et al The methodological quality assessment tools for preclinical and clinical studies, systematic review and meta‐analysis, and clinical practice guideline: a systematic review. J Evid Based Med 2015; 8:2–10. - PubMed
-
- Health Improvement Scotland . SIGN100: a handbook for patient and carer representatives. Available at: https://www.sign.ac.uk/sign-100-a-handbook-for-patient-and-carer-represe... (last accessed 2 July 2019).
-
- Yenamandra VK, Moss C, Sreenivas V et al Development of a clinical diagnostic matrix for characterizing inherited epidermolysis bullosa. Br J Dermatol 2017; 176:1624–32. - PubMed
-
- Almaani N, Liu L, Dopping‐Hepenstal PJC et al Identical glycine substitution mutations in type VII collagen may underlie both dominant and recessive forms of dystrophic epidermolysis bullosa. Acta Derm Venereol 2011; 91:262–6. - PubMed